ARTICLE | Clinical News

SRF231: Preclinical data

November 18, 2016 6:32 PM UTC

In a mouse xenograft model of lymphoma, SRF231 plus Rituxan rituximab led to a greater reduction in tumor volume vs. Rituxan alone. Data were presented at the Society for Immunotherapy of Cancer meeti...

BCIQ Company Profiles

Surface Oncology Inc.

BCIQ Target Profiles